Current Protein Identity:Q12923 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1D5G SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E COMPLEXED WITH A PEPTIDE Deposited 1999-10-07 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1361–1456(96 aa) Fragment:PDZ2 DOMAIN
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR measurement conditions pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR measurement conditions pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR measurement conditions pH 6.8;293 K;Ionic strength (raw mmCIF value) 0.15 M NACL;Pressure AMBIENT
NMR sample composition 1.0-5.0 MM OF N15-LABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED PEPTIDE
NMR sample composition 1.0-5.0 MM OF UNLABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED PEPTIDE
NMR sample composition 1.0-5.0 MM OF UNLABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED PEPTIDE
NMR sample composition 1.0-5.0 MM OF DOUBLE-LABELED PDZ2 DOMAIN WITH 20% MOLAR EXCESS OF UNLABELED PEPTIDE
Resolution not provided
1Q7X Solution structure of the alternatively spliced PDZ2 domain (PDZ2b) of PTP-Bas (hPTP1E) Deposited 2003-08-20 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1357–1464(108 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.8;293 K;Ionic strength (raw mmCIF value) 50mM sodium phosphate, 150mM sodium chloride;Pressure ambient
NMR sample composition 2mM PDZ2b U-15N, 13C; 50mM phosphate buffer with 150mM sodium chloride | 92% H20, 8% D2O
NMR sample composition 2mM PDZ2b U-15N; 50mM phosphate buffer with 150mM sodium chloride | 92% H20, 8% D2O
NMR sample composition 2mM PDZ2b unlabeled; 50mM phosphate buffer with 150mM sodium chloride | 92% H20, 8% D2O
Resolution not provided
1WCH Crystal structure of PTPL1 human tyrosine phosphatase mutated in colorectal cancer - evidence for a second phosphotyrosine substrate recognition pocket Deposited 2004-11-16 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2163–2477(315 aa) Fragment:RESIDUES 2163-2477
Not recorded PO4 PHOSPHATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION
Resolution 1.85 Å R-free 0.204
2M0Z cis form of a photoswitchable PDZ domain crosslinked with an azobenzene derivative Deposited 2012-11-09 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1361–1456(96 aa) Fragment:PDZ 2 domain residues 1361-1456
Mutation:S1381C, E1436C 33B 3,3'-(E)-diazene-1,2-diylbis{6-[(chloroacetyl)amino]benzenesulfonic acid} × 1 SOLUTION NMR
NMR measurement conditions pH 6.8;298 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition 0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 4.3 % C12E5, 1.8 % n-hexanol, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 8.5 mg/mL Pf1 phage, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 0.75 mM [U-99% 13C; U-99% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2M10 trans form of a photoswitchable PDZ domain crosslinked with an azobenzene derivative Deposited 2012-11-09 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1361–1456(96 aa) Fragment:PDZ 2 domain residues 1361-1456
Mutation:S1381C, E1436C 33B 3,3'-(E)-diazene-1,2-diylbis{6-[(chloroacetyl)amino]benzenesulfonic acid} × 1 SOLUTION NMR
NMR measurement conditions pH 6.8;298 K;Ionic strength (raw mmCIF value) 0.2;Pressure ambient
NMR sample composition 0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 4.3 % C12E5, 1.8 % n-hexanol, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 0.75 mM [U-100% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 8.5 mg/mL Pf1 phage, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 0.75 mM [U-99% 13C; U-99% 15N] protein, 50 mM sodium phosphate, 150 mM sodium chloride, 0.1 mM sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
3LNX Second PDZ domain from human PTP1E Deposited 2010-02-03 Assembly 1 Protein homooligomer Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 1361–1456(96 aa) Fragment:PDZ2 domain
Chain B 1361–1456(96 aa) Fragment:PDZ2 domain
Chain C 1361–1456(96 aa) Fragment:PDZ2 domain
Chain D 1361–1456(96 aa) Fragment:PDZ2 domain
Chain E 1361–1456(96 aa) Fragment:PDZ2 domain
Chain F 1361–1456(96 aa) Fragment:PDZ2 domain
Not recorded IOD IODIDE ION × 25 SCN THIOCYANATE ION × 14 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;28% PEG 3350, 0.2 M KI, 0.2 M NaSCN, 0.1 M NaAc, pH 4.5, hanging drop, temperature 298K, VAPOR DIFFUSION, HANGING DROP
Resolution 1.64 Å R-free 0.237
3LNY Second PDZ domain from human PTP1E in complex with RA-GEF2 peptide Deposited 2010-02-03 Assembly 1 Protein heterocomplex Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 1361–1456(96 aa) Fragment:PDZ2 domain
Not recorded SCN THIOCYANATE ION × 6 SO4 SULFATE ION × 12 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;20% PEG 3350, 0.8 M (NH4)2SO4, 0.2 M NaSCN, 0.1 M Na citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 1.30 Å R-free 0.189
3PDZ SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E Deposited 1999-05-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1361–1456(96 aa) Fragment:PDZ2 DOMAIN
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.8;293 K;Pressure 1
NMR sample composition 10% D2O/90% WATER
Resolution not provided
5GLJ Crystal Structure of PDZ1 Domain of Human Protein Tyrosine Phosphatase PTP-Bas Deposited 2016-07-11 Assembly 1 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1086–1178(93 aa) Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
Chain B 1086–1178(93 aa) Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
Chain C 1086–1178(93 aa) Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
Chain D 1086–1178(93 aa) Fragment:PDZ1 Domain (UNP RESIDUES 1086-1178)
Not recorded CL CHLORIDE ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.2 M Magnesium chloride hexahydrate , 0.1 M BIS-TRIS pH5.5, 25 % w/v Polyethylene glycol 3350
Resolution 1.60 Å R-free 0.206
7QCX Two-state liquid NMR Structure of a PDZ2 Domain from hPTP1E, apo form Deposited 2021-11-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1361–1456(96 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.8;298 K;Ionic strength (raw mmCIF value) 150;Pressure 1
NMR sample composition 2.0 mM [U-100% 13C; U-100% 15N] PDZ2 domain from hPTP1E, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
7QCY Two-state liquid NMR Structure of a PDZ2 Domain from hPTP1E, complexed with RA-GEF2 peptide Deposited 2021-11-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1361–1456(96 aa)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.8;298 K;Ionic strength (raw mmCIF value) 150;Pressure 1
NMR sample composition 2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
7XTY Crystal Structure of the second PDZ domain from human PTPN13 in complex with APC peptide Deposited 2022-05-18 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1362–1456(95 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 6.8;289 K;0.1M citric acid (pH 3.5), 3M NaCl
Resolution 2.10 Å R-free 0.240
7XTY Crystal Structure of the second PDZ domain from human PTPN13 in complex with APC peptide Deposited 2022-05-18 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1362–1456(95 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 6.8;289 K;0.1M citric acid (pH 3.5), 3M NaCl
Resolution 2.10 Å R-free 0.240